Feifei Cheng
Impact in
- Aging top 10%
- Obstetrics and Gynecology top 10%
- Gestational Diabetes Research and Management
Papers in
-
- Gestational Diabetes Research and Management 6
- Physiology 10
- Telomeres, Telomerase, and Senescence 9
- Co-authors
- Ronald C W Ma (9 shared papers)Anandwardhan A. Hardikar (7 shared papers)Mugdha V. Joglekar (6 shared papers)Alicia Josephine Jenkins (7 shared papers)Luke M. Carroll (2 shared papers)Andrzej S. Januszewski (1 shared paper)Wilson K. M. Wong (1 shared paper)Cadmon King Poo Lim (8 shared papers)
In The Last Decade
Feifei Cheng
37 papers receiving 927 citations
Feifei Cheng's Hit Papers
Peers
Comparison fields: 5 of 90
- Aging 34
- Obstetrics and Gynecology 90
- Endocrinology, Diabetes and Metabolism 185
- Physiology 278
- Genetics 159
Countries citing papers authored by Feifei Cheng
This map shows the geographic impact of Feifei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Cheng more than expected).
Fields of papers citing papers by Feifei Cheng
This network shows the impact of papers produced by Feifei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Cheng. The network helps show where Feifei Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 154 | |
| 2 | Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine Hit paper breakdown → | 2023 | 146 |
| 3 | 2023 | 63 | |
| 4 | 2022 | 62 | |
| 5 | 2020 | 50 | |
| 6 | 2020 | 48 | |
| 7 | 2024 | 34 | |
| 8 | 2024 | 33 | |
| 9 | 2024 | 32 | |
| 10 | 2023 | 26 | |
| 11 | 2023 | 24 | |
| 12 | 2023 | 24 | |
| 13 | 2021 | 21 | |
| 14 | 2015 | 20 | |
| 15 | 2023 | 19 | |
| 16 | 2023 | 19 | |
| 17 | 2023 | 18 | |
| 18 | 2024 | 17 | |
| 19 | 2021 | 14 | |
| 20 | 2023 | 14 |
About Feifei Cheng
Feifei Cheng is a scholar working on Obstetrics and Gynecology, Physiology, Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Genetics, having authored 38 papers that have together received 938 indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (9 papers), Gestational Diabetes Research and Management (6 papers), Ovarian function and disorders (4 papers), Diabetes and associated disorders (3 papers), Pancreatic function and diabetes (3 papers), Diabetes Management and Research (2 papers), Energy and Environment Impacts (1 paper) and Ovarian cancer diagnosis and treatment (1 paper). The work is most often cited by research in Aging (34 citations), Obstetrics and Gynecology (90 citations), Endocrinology, Diabetes and Metabolism (185 citations), Physiology (278 citations) and Genetics (159 citations). Feifei Cheng has collaborated with scholars based in Hong Kong, Australia and China. Frequent co-authors include Ronald C W Ma, Anandwardhan A. Hardikar, Mugdha V. Joglekar, Alicia Josephine Jenkins, Luke M. Carroll, Andrzej S. Januszewski, Wilson K. M. Wong, Cadmon King Poo Lim, Juliana Chan and Baoqi Fan. Their work appears in journals such as Diabetes Care, Journal of Affective Disorders, Diabetologia, Frontiers in Public Health and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.